Portfolio company
Vir Biotechnology
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops antibody-based medicines and immunotherapies for patients with serious infectious diseases and cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
Immunitas Therapeutics
This company develops antibody therapeutics for patients with cancer and autoimmune diseases.
Vir
This clinical-stage biopharmaceutical company develops medicines for serious infectious diseases and cancer for global patients.
Asher Biotherapeutics
This biotechnology company develops targeted immunotherapies for patients with cancer, infectious diseases and autoimmune conditions.
Cidara Therapeutics
This biotechnology company develops immunotherapies and long-acting antivirals for patients suffering from serious infectious diseases and solid tumours.
Virion
The company develops T cell immunotherapies for patients with cancer and chronic infectious diseases.
AbCellera Biologics
The company develops antibody-based medicines and discovery technologies for pharmaceutical and biotechnology partners to treat cancer, autoimmune disorders and infectious diseases.
Pionyr Immunotherapeutics
This company develops antibody therapeutics that modify the tumor microenvironment to treat cancer patients.